Nonalcoholic Fatty Liver Disease—A Novel Risk Factor for Recurrent <i>Clostridioides difficile</i> Infection

Recurrent <i>Clostridioides difficile</i> infections (rCDI) have a substantial impact on healthcare systems, with limited and often expensive therapeutic options. Nonalcoholic fatty liver disease (NAFLD) affects about 25% of the adult population and is associated with metabolic syndrome, changes in...

Descrizione completa

Dettagli Bibliografici

Autori principali:	Lara Šamadan, Mia Jeličić, Adriana Vince, Neven Papić
Natura:	Artigo
Lingua:	Inglês
Pubblicazione:	MDPI AG 2021-06-01
Serie:	Antibiotics
Soggetti:	<i>Clostridioides difficile</i> associated disease CDI nonalcoholic fatty liver disease NAFLD NASH recurrent disease
Accesso online:	https://www.mdpi.com/2079-6382/10/7/780
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!